| pubmed-article:11353598 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11353598 | lifeskim:mentions | umls-concept:C0076829 | lld:lifeskim |
| pubmed-article:11353598 | lifeskim:mentions | umls-concept:C0005911 | lld:lifeskim |
| pubmed-article:11353598 | lifeskim:mentions | umls-concept:C2678248 | lld:lifeskim |
| pubmed-article:11353598 | lifeskim:mentions | umls-concept:C0023983 | lld:lifeskim |
| pubmed-article:11353598 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:11353598 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11353598 | pubmed:dateCreated | 2001-5-16 | lld:pubmed |
| pubmed-article:11353598 | pubmed:abstractText | Topiramate is an antiepileptic agent, which is being investigated as a mood-stabilizer. Three obese individuals with DSM-IV bipolar I disorder and type II diabetes mellitus received topiramate treatment in combination with antipsychotics and valproate or carbamazepine. In addition to improved mood stability, these individuals lost between 16 to 20.5% of their pre-topiramate body weight and also achieved significant glycemic control. | lld:pubmed |
| pubmed-article:11353598 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11353598 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11353598 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11353598 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11353598 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11353598 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11353598 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11353598 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:11353598 | pubmed:issn | 0924-9338 | lld:pubmed |
| pubmed-article:11353598 | pubmed:author | pubmed-author:LevineJJ | lld:pubmed |
| pubmed-article:11353598 | pubmed:author | pubmed-author:RathoreDD | lld:pubmed |
| pubmed-article:11353598 | pubmed:author | pubmed-author:ParepallyHH | lld:pubmed |
| pubmed-article:11353598 | pubmed:author | pubmed-author:AtzertRR | lld:pubmed |
| pubmed-article:11353598 | pubmed:author | pubmed-author:Roy... | lld:pubmed |
| pubmed-article:11353598 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11353598 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:11353598 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11353598 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11353598 | pubmed:pagination | 186-90 | lld:pubmed |
| pubmed-article:11353598 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:meshHeading | pubmed-meshheading:11353598... | lld:pubmed |
| pubmed-article:11353598 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11353598 | pubmed:articleTitle | Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series. | lld:pubmed |
| pubmed-article:11353598 | pubmed:affiliation | Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, 3811 O'Hara Street, Pittsburgh, PA 15213-2593, USA. chengappakn@msx.upmc.edu | lld:pubmed |
| pubmed-article:11353598 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11353598 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11353598 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11353598 | lld:pubmed |
